Seevix Material Sciences Ltd. is a privately-held biotech company producing the high-strength SVX™, a state-of-the-art biopolymer material, inspired by spider silk, capable of endowing everyday products with all of its outstanding properties. When assimilated into various materials, SVX enhances their physical properties, enabling the development of sustainable, lighter, thinner, and tougher composites as building blocks for the next generation of customizable, high-performance products that will change the way we live.
As part of the celebrations surrounding the Summer Olympics in Japan, ASICS, a leading manufacturer of sports shoes, highlighted its collaboration and investment in Seevix in the media and in an exhibit featuring the use of SVX in its “Future Shoes”.
In its introduction to a video about SVX in its Olympics exhibition hall, ASICS, whose mission is “to provide goods and services that promote healthy and fulfilling lifestyles throughout the world,” stated:
“In this video exhibit, we introduce a new fiber material of protein origin. SVX is an ultra-fine bioprotein fiber with the lightness, durability and elasticity of spider silk. Most significantly, it is produced through the fermentation of proteins through microorganisms, which makes it biodegradable. ASICS is currently developing products that incorporate this remarkable new material. SVX is just part of a long-term initiative for realizing a sustainable future: creating shoes that ultimately return to nature.”
SVX’s outstanding properties can be used to reinvent many products for use in the sports, medical devices, cosmetics, defense, textiles, and automotive and aerospace industries.
When incorporated into skin and hair care formulations, SVX, which is porous and can be loaded with active ingredients, creates exciting opportunities for cosmetic applications.
Other possible applications for SVX include thinner stronger surgical sutures, lightweight durable scaffolds for orthopedic reconstructive surgery, surgical meshes, dental and orthopedic implants, and bio-dressings to boost wound healing.
Products using SVX are in early sales (SpheroSeev for 3D cell culture), near-term entry into the market (skin and hair care products), and POC (collaborations with ASICS and other leading multinational corporations in other industries for the development of their next-generation products).
Seevix Material Sciences Ltd. is a privately-held biotech company established in 2014 as a spinoff from Yissum, the technology transfer arm of the Hebrew University of Jerusalem. Its patented SVX synthetic spider silk, backed by over ten years of research at the Hebrew University, targets applications where the addition of SVX’s extraordinary properties and biocompatibility can radically improve existing products and provide solutions for unmet industrial needs. SVX is manufactured by means of a single-step production process, enabling scalable, green, commercial manufacturing that reduces production time and costs. Seevix’s exceptional multidisciplinary R&D team of biologists, chemists, and material engineers is dedicated to creating next-generation SVX-based products in a host of different industries, providing its partners with a sustainable competitive edge.
Funding Status: Seevix is seeking investors and strategic partners to raise $15 million for an industrial-scale spider silk manufacturing facility in Israel and for its marketing and sales operations.
For further information please contact Dr. Shomzion Shen (shlomzi AT seevix.com) or visit the website (www.seevix.com)
About JLM- BioCity
News on the many life science and healthcare companies in the Jerusalem area can be seen at https://jlm-biocity.org/jlm-biocity-innovations/. Join the JLM-BioCity linkedin group at https://www.linkedin.com/groups/7060787 to get the news updates sent to you and to be part of the JLM-BioCity community.
JLM-BioCity is a non-profit organization focused on developing and excelling Jerusalem’s bio-community.
We invite you, researcher, professional, investor and executive to become part of our vision, in building Jerusalem’s Biomed eco-system.
If you want your Company featured in our blogs , news releases, please contact: info AT jlm-biocity.org